The Von Willibrand Disease Treatment Market in North America continues to expand as healthcare systems prioritize the early diagnosis and effective management of inherited bleeding disorders. The region benefits from advanced healthcare infrastructure, increasing investments in rare disease research, supportive reimbursement frameworks, and the growing availability of innovative recombinant...